Boston Scientific Corp. announced Monday that it has completed the sale of its Cardiac Surgery and Vascular Surgery businesses to the Getinge Group of Sweden for $750 million in cash.
Boston Scientific completes sale of Cardiac Surgery and Vascular Surgery businesses